New technology to assist research and genetic drug delivery
Wednesday, March 24, 2010 - 17:35
in Biology & Nature
Techulon, Inc., and University of Cincinnati sign worldwide exclusive license agreements to manufacture and sell novel reagents used for research and therapeutic delivery of nucleic acids.
